雖然這篇Syncona鄉民發文沒有被收入到精華區:在Syncona這個話題中,我們另外找到其它相關的精選爆讚文章
[爆卦]Syncona是什麼?優點缺點精華區懶人包
你可能也想看看
搜尋相關網站
-
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#1Syncona – building the next generation of global leaders in ...
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#2Syncona Limited | LinkedIn
Syncona, is a leading FTSE 250 healthcare company focused on founding, building and funding a portfolio of global leaders in life science.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#3Syncona Partners LLP - Crunchbase Investor Profile ...
Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#4Syncona Limited Share Price (SYNC) Ordinary NPV
The investment objective is to deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#5SYNCS.L - Syncona Ltd Profile | Reuters
Syncona Limited is a Guernsey-based closed-ended investment company. The Company's investment objective is to achieve superior long-term capital ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6Syncona - Wikipedia
Syncona (LSE: SYNC) is a large British closed-ended investment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#7Syncona Limited (SYNC.L) 公司概況及事件 - Yahoo財經
CIO & Managing Partner of Syncona Investment Management Ltd. 無, 無, 1975. Ms. Annabel Clay, Head of Investor ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#8Syncona (@SynconaLtd) / Twitter
Syncona. @SynconaLtd. Founding, Building and Funding a portfolio of ... Today Syncona announces that portfolio company Gyroscope Therapeutics is to be ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#9Syncona Limited, SYNC:LSE summary - FT.com - Markets data
Latest Syncona Limited (SYNC:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#10Syncona Investment Management Ltd - Company Profile and ...
Syncona Investment Management Limited operates as a venture capital firm. The Company invests in life science sector. Syncona Investment Management serves ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#11Syncona Limited (Ordinary Share) SYNC - Citywire
To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#12Syncona Limited Key Statistics | GG00B8P59C08 | Fidelity
Key statistics for Syncona Limited (GG00B8P59C08) plus portfolio overview, latest price and performance data, expert insights and more.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#13Syncona Investment Management Limited | BIA - BioIndustry ...
Syncona (LON: SYNC) is a healthcare company focused on founding, building and funding a portfolio of global leaders in life science.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#14Syncona Ltd share price and latest news - The Telegraph
(Alliance News) - Syncona Ltd on Friday said it has completed the sale of Gyroscope Therapeutics Holding PLC to Novartis AG.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#15Syncona Ord (SYNC) Quote | Morningstar
Syncona Limited · Last Closing Share Price. 170.40 · Day Range. 158.20 – 172.40 · Year Range. 158.20 – 272.49 · Market Capitalisation GBP. 1.1 Bil · Income Only ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#16Syncona Limited (SYNC) - Shares Magazine
Name, Syncona Limited, Epic, SYNC. ISIN, GG00B8P59C08, Currency, GBX. Type, CEF, Trading Segment, STMM. Record Status, Active, Trading Status ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#17Syncona Limited Ord NPV Fund factsheet | Trustnet
Syncona Limited Ord NPV. AIC Sector: IT Biotechnology & Healthcare (View sector) ... This fund does not subscribe to Trustnet. ... The Company's existing investment ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#18Share tip: Syncona offers a chance to back the next science ...
For those looking for a way to invest in early-stage science since the implosion of Woodford Patient Capital Trust, Syncona may offer a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#19Syncona Definition | Law Insider
Define Syncona. means a non-cellular company limited by shares incorporated in Guernsey with registered number 62778.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#20Syncona : SYNC - QuotedData
Syncona : SYNC (formerly Battle Against Cancer Investment Trust or BACIT - ticker BACT) aims to be a leading, self-managed, life science investment company.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#21Syncona Limited | GFSC
The Protection of Investors (Bailiwick of Guernsey) Law, 2020. Syncona Limited is a registered collective investment scheme.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#22All trades: Syncona announces sale of portfolio company to ...
Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale of its portfolio ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#23SYNCONA LIMITED SYNC Our story - London Stock Exchange
Syncona is a leading FTSE250 healthcare company focused on founding, building and funding a portfolio of global leaders in life science.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#24Syncona | The AIC
To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#25Syncona Partners - CB Insights
Syncona Partners was founded in 2012 and operates as an evergreen investment company, taking an active role in identifying, supporting and developing ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#26Syncona Internship | windsor-fellowship
Syncona is a FTSE 250 healthcare company focused on creating global leaders in life sciences. We operate as a hands-on venture capital, working closely with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#27Syncona Ltd Company Profile - GlobalData
Syncona Ltd (Syncona) is a closed-ended investment company. The company invests in long-only funds, hedge funds, private equity funds and real estate funds.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#28SYNCONA (SYNC) | InvestEgate
Date Time Source Announcement 18 Feb 2022 7:00 am RNS Completion of sale of Gyroscope Therapeutics 10 Feb 2022 7:00 am RNS 3rd Quarter Results 08 Feb 2022 12:05 pm RNS Freeline presents data in Fabry disease
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#29Kepler Partners - Syncona - Trust Intelligence
Syncona is a unique vehicle offering exposure to high growth, although not without risks...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#30ii ACE 40 investments: Syncona IT - Interactive Investor
Focus on life sciences: Syncona is focused on founding, building and funding companies in innovative areas of science and is an established leader in cell ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#31Syncona slips as NAV hit by Autolus share price fall
Syncona Limited (LON:SYNC) shares dipped on Thursday as the life science investor saw its net asset value (NAV) was hit by an 81% decline in the value of its ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#32SYNCONA INVESTMENT MANAGEMENT LIMITED overview
SYNCONA INVESTMENT MANAGEMENT LIMITED - Free company information from Companies House including registered office address, filing history, accounts, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#33SYNC.L | Syncona Limited NPV | Share Prices & News In One ...
Freeline presents data in Fabry disease. Syncona Ltd, a leading healthcare company focused on founding, building and funding global leaders in life science, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#34Syncona Ltd (SYNC) Stock Price & News - Google Finance
Get the latest Syncona Ltd (SYNC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#35Syncona cornerstones $148 million Series C financing in ...
Life sciences investment trust Syncona (LSE: SYNC) has invested $42.3 million UK-based Gyroscope Therapeutics, a clinical-stage gene therapy ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#36SYNCONA LIMITED ORD NPV SYNC - Factsheet - Charles ...
Syncona Limited is a Guernsey-based closed-ended investment company. The Company's investment objective is to achieve superior long-term capital appreciati.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#37James Carthew: Syncona has cash for life sciences land grab
In August 2018 I questioned the 51% premium that life sciences investment company Syncona (SYNC) was then trading on and queried its high ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#38SYNC: Syncona Limited - Stock Price, Quote and News - CNBC
Get Syncona Limited (SYNC:London Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#39Syncona | The Irish Times
European shares ended on Wednesday at near one-week highs, led by gains in technology and industrial stocks, even as investors worried about ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#40Syncona Internship 2021 | The VALIDATE Network
Take part in Syncona's full operating rhythm, attend internal meetings and be exposed to all new investment opportunities explored by the team.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#41Syncona joins Gyroscope, Orbit to create eye gene therapy ...
Syncona will own 82% of the merged company, with the value of its holding estimated at around £28.9 million (around $38 million). Eye diseases ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#42Syncona Ltd. | BioWorld
LONDON – Syncona Ltd. has unveiled its fifth cell therapy startup, Resolution Therapeutics Ltd., which arrives on the scene with a £26.6 million (US$35.6 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#43Syncona - Investment Week
Majority trading on a discount. clock 10 February 2022 • 3 min read. interactive investor keeps Syncona on ACE 40 list following review ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#44Syncona Investment Management Limited | Signatory profile
Syncona Investment Management Limited. Signed the Principles: 20 October 2021. Signatory category: Investment Manager; HQ: United Kingdom.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#45Facilitating research commercialisation opportunities
Last month NIHR Imperial BRC welcomed Venture Capital investors Syncona at a pitching and networking event, organised by colleagues at ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#46Syncona portfolio company Autolus appoints Martin Murphy ...
Healthcare and life science investor Syncona has announced that chief executive of Syncona Investment Management Martin Murphy has been ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#47News | SYNCONA Stock Price Today | Analyst Opinions
Syncona Ltd. is a closed-end investment fund. It engages in delivering returns from investments in long and alternative investment funds across multiple ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#48Syncona: a biotech trust that's going for a song | MoneyWeek
Syncona is an investment trust that invests in promising, privately-held biotechnology companies. It looks too cheap. · The contents of Syncona's ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#49Syncona Price & Performance | Bestinvest
Syncona. 185.00p Sell; 181.40p Buy. Initial charge; 1.54% Ongoing charges; 0.00% Yield. Prices as at 25 January 2022, fund commentary last ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#50Syncona, CRUK and BACIT join forces to create a $1.2B ...
Wellcome created Syncona four years ago, investing £250 million into its subsidiary to help provide some badly needed financing for the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#51Syncona makes a further $80 million commitment to Freeline
Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, has announced Syncona Ltd ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#52Syncona makes a further $80 million commitment to Freeline
London, 19 December 2019 – Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#53Wellcome Trust Sanger Institute Spinout 14M Genomics And ...
14M Genomics and Syncona sign £12.5 million financing to develop cancer genomic diagnostics in partnership with the Wellcome Trust Sanger ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#54Syncona | FierceBiotech
Syncona committed £85 million to Freeline, maintaining a big stake in a biotech that aims to redefine treatment of hemophilia B and Fabry disease.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#55Syncona founds Quell Therapeutics with £35m Series A - UKTN
Syncona has announcesdthe foundation of Quell Therapeutics, a new cell therapy company with a £35 million commitment in a Series A financing ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#56Life sciences podcast: Clusters beyond OxCam Arc needed ...
Alex Hamilton is a partner at Syncona Investment Management, a FTSE 250 venture capital firm that invests in early-stage life sciences firms ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#57Syncona Share Price. SYNC - Stock Quote, Charts, Trade ...
Syncona Limited Ord Npv is listed on the London Stock Exchange, trading with ticker code SYNC. It has a market capitalisation of £1080m, with approximately ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#58Syncona expects 3-month delay in clinical trials during COVID ...
Companies funded by Syncona are sidelining certain elective procedures or surgeries and clinical trials as COVID-19 — a respiratory disease ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#59CMS advised Syncona Ltd on investment in Anaveon AG
CMS advised Syncona Ltd on a CHF 35 million financing in Anaveon AG, a new immuno-oncology company.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#60Syncona cornerstones $148m Series C in Gyroscope
Healthcare company Syncona has injected $42.3m of that sum and now holds a 54 per cent stake in the fast-growing business.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#61Syncona — Work - SampsonMay
Syncona. Articulating a new purpose and positioning for a leading life sciences investment company. Syncona are a FTSE 250 biotech investment company that ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#62Syncona to join forces with leading investment trust - Wellcome
A proposal to combine Syncona – an independent subsidiary of Wellcome – with a leading investment company is announced today.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#63Bracco's Blue Earth buy boosts Syncona | Evaluate
Syncona might have hoped for a bigger payday with the prostate imaging specialist, but it has plenty more irons in the fire.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#64From Novartis to Syncona - European Biotechnology
London-based Syncona Ltd announces the appointment of Danny Bar-Zohar as Syncona Partner, starting mid of April.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#65Gyroscope takeout, one of UK's largest, gives Syncona ...
Gyroscope takeout, one of U.K.'s largest, gives Syncona another gene therapy exit. Novartis pays $800M up front for ophthalmic play; ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#66Syncona Ltd - London Stock Exchange
Syncona presents its Full Year results for the 2021 financial year. Q&A - If you wish to participate in live Q&A after the presentation, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6714M Genomics and Syncona Sign £12.5m Financing
14M Genomics and Syncona sign £12.5 million financing to develop cancer genomic diagnostics in partnership with the Wellcome Trust Sanger ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#68Syncona sells portfolio startup Gyroscope to Novartis for £1.1bn
Shares in life sciences investor Syncona closed 5.5 per cent higher today after it announced the sale of its London-based gene therapy ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#69Syncona net asset value slips in first half - Sharecast.com
Healthcare investor Syncona reported net assets of £1.15bn at the end of its first half on Thursday, or 171.7p per share, down from £1.3bn ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#70SYNCONA PORTFOLIO LTD Institutional Portfolio | Nasdaq
SYNCONA PORTFOLIO LTD. 3RD FLOOR, ARNOLD HOUSE, ST PETER PORT, , GY1 3RD, (144203) 981-7909. Report last updated Dec 31, 2021 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#71Syncona co-leads Series B financing in Quell Therapeutics of ...
Syncona co-led the financing round alongside specialist global institutional investors Jeito Capital, Ridgeback Capital Investments, SV Health ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#72Quell Therapeutics, founded by Syncona Ltd, appoints Chief ...
Iain McGill, Chief Executive Officer of Quell Therapeutics added: “I am delighted to be leading such an exciting company. With Syncona's vision ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#73THE SYNCONA FOUNDATION - 1149202 - Charity Commission
The Syncona Foundation ("Foundation") receives an annual donation from Syncona Limited. The Foundation grants those funds to charities selected by its ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#74Syncona Investment Management Limited - The Law Society
Syncona Investment Management Limited. Organisation details - click to Hide Show. Type: Not an SRA-regulated law practice; SRA ID: 640688.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#75Syncona Foundation Scholarship Partnership - Generating ...
Thanks to Syncona and our other funders, we have been able to put our vision into action. The scholarship fund from Syncona is called the David Twumasi Syncona ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#76Syncona Investment Management Profile - PitchBook
Syncona Investment Management is a private investment firm based in London, United Kingdom. Established in 2016, the firm is the investment arm for Syncona, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#77Syncona invests $80m in Freeline's systemic disease gene ...
Syncona invests $80m into Freeline's Series C financing round to support continued development of its gene therapies for systemic diseases.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#78Syncona 3Q Net Asset Value Rose; Portfolio Companies ...
By Anthony O. Goriainoff Syncona Ltd. said on Thursday that its net asset value rose 16% in the third quarter compared with the previous ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#79Syncona founds Purespring with a £45m Series A Financing
Syncona's Chief Investment Officer, Chris Hollowood, has been appointed as Chairman and Syncona Partner Dominic Schmidt will be joining the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#80Syncona Company Profile - Office Locations, Competitors ...
See insights on Syncona including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#81SYNCONA PORTFOLIO LTD Top 13F Holdings
Syncona Portfolio LTD is based out of St Peter Port. Their last reported 13F filing for Q4 2021 included $104,681,000 in managed 13F securities and a top 10 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#82Syncona-维基百科 - 百科全书
Syncona (伦敦证券交易所: 同步)很大英式 封闭式投资信托 致力于生命科学投资。该公司成立于2012年10月,是抗癌投资信托基金('BACIT')的上市公司。
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#83Building for future success: the Syncona Partners model
Martin Murphy is Chief Executive Officer of Syncona Investment Management Ltd. He co-founded Syncona in 2012 with The Wellcome Trust.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#84Syncona Appoints Kenneth Galbraith as Executive in Residence
Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#85Syncona LTD - YouTube
Syncona leads $87m Series A financing of Clade Therapeutics. 31 views4 months ago. 6:19 Now playing · Anaveon doses first patient. 27 views8 months ago.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#86Syncona : Anaveon to present first clinical data from the Phase ...
18 小時前 — SYNCONA LIMITED. BACT. Delayed Quote. Delayed - 03/09 04:01:38 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#87University Technology Transfer: What It Is and How to Do It
“Launch of Syncona Partners,” Wellcome, January 3, 2013, https:// well come. ac . uk / press release / launch syncona partners; Syncona has grown ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#88Science, the State and the City: Britain's Struggle to ...
Wellcome's next step , in 2012 , was to create a £ 200m healthcare investment fund , Syncona Partners , which would seek to build healthcare businesses on a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#89SwanBio Therapeutics to Present New Preclinical Data ...
SwanBio is supported by long-term, committed investment partners, including its primary investors Syncona, Ltd. (lead investor and majority ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#90European Open: Sentiment remains buoyant, bear flag on ...
+ 8.56% - Syncona Ltd (SYNCS.L). Underperformers: -59.76% - Petropavlovsk PLC (POG.L); -41.66% - EVRAZ plc ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#91Freeline Therapeutics Holdings plc (NASDAQ:FRLN) Given ...
Syncona Portfolio Ltd bought a new stake in Freeline Therapeutics in the 4th quarter worth about $5,841,000. Harbor Capital Advisors Inc.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#92OMass Establishes Scientific Advisory Board of Leading ...
Headquartered in Oxford, UK, OMass is backed by a top-tier investor syndicate, Syncona and Oxford Science Enterprises, having closed a ~$60m ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#93Miss Lou: Louise Bennett and Jamaican Culture
Toronto: Syncona SLBC002,,n .d ., PO Box 865, Adelaide St . E . Stn ., Toronto, Ontario, Canada M5C 2K1 . [Audio . Cassette . LB tells Anancy stories] Miss ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#94Making West Indian Literature - 第 82 頁 - Google 圖書結果
Audio cassettes or CDs include Miss Lou's Views (Syncona SLBC 001, P.O. Box 865, Adelaide St Stn., Toronto, Ontario, Canada M5C 2K1) and Bre' Anancy & Miss ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#95Shares have hardly modified amid slight profit-taking - DAILY ...
Syncona Limited NPV (SYNC) 197.40 p -2.86% Hilton Food Group (HFG) 1,084.00p -2.53% Beazley 485.00p -2.26%.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#96Your #Scorpio Week Ahead #Horoscope from 25th Nov 2017
... Lok'N'Store, Safestore, Big Yellow, BBOX, EBOX, PCA, TPXimpact, Syncona, Topps Tiles, VTU, PDG, Omicron, FTSE Investing.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?>
syncona 在 コバにゃんチャンネル Youtube 的最佳貼文
syncona 在 大象中醫 Youtube 的最佳解答
syncona 在 大象中醫 Youtube 的最佳貼文